• No results found

[PDF] Top 20 Engineering multi specific antibodies against HIV 1

Has 10000 "Engineering multi specific antibodies against HIV 1" found on our website. Below are the top 20 most common "Engineering multi specific antibodies against HIV 1".

Engineering multi specific antibodies against HIV 1

Engineering multi specific antibodies against HIV 1

... bispecific antibodies that utilize asymmetry, such as the CrossMAb format, cannot be distinguished from homodimer impurities since the Fc regions of both the target heterodimer product and the impurity con- ... See full document

17

Isolation of Specific Human Recombinant Antibodies Against Glycoprotein 41 of HIV

Isolation of Specific Human Recombinant Antibodies Against Glycoprotein 41 of HIV

... monoclonal antibodies (mAbs) have been considered that target the gp41 ...neutralizing antibodies are largely strain-specific that is one of the problems for the use of them, and therefore would not ... See full document

8

Engineering Immunity Against HIV

Engineering Immunity Against HIV

... informative. We are currently studying the Molecular Rheostat immunoglobulin system using an alternative retroviral vector system adapted for murine cells (pMIG). Second, an alternate path to anti-HIV B-cell ... See full document

108

HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis

HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis

... efficacious HIV-1 vaccine ...nonneutralizing antibodies can mediate some protection against HIV in animal ...of HIV-1-specific IgG, more studies are needed on the functional ... See full document

18

HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies

HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies

... activity against HIV-1 variability FIG 7 Sample calculation of percent log efficiency of suppression by CAR-transduced ...of 1:4. (Left) The HIV-1 p24 antigen level was measured ... See full document

8

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies

Longer V1V2 Region with Increased Number of Potential N-Linked Glycosylation Sites in the HIV-1 Envelope Glycoprotein Protects against HIV-Specific Neutralizing Antibodies

... type 1 (HIV-1) has the ability to adapt to the host environment by escaping from host immune ...regions 1 and 2 ...of HIV-1 to neutralizing ...-resistant HIV-1 ... See full document

10

Maturational characteristics of HIV-specific antibodies in viremic individuals

Maturational characteristics of HIV-specific antibodies in viremic individuals

... given HIV-infected individuals, HIV-specific B cells were enriched within AM and TLM B cell populations, whereas B cells specific for non-HIV pathogens such as influenza and tetanus ... See full document

18

The Breadth and Titer of Maternal HIV-1-Specific Heterologous Neutralizing Antibodies Are Not Associated with a Lower Rate of Mother-to-Child Transmission of HIV-1

The Breadth and Titer of Maternal HIV-1-Specific Heterologous Neutralizing Antibodies Are Not Associated with a Lower Rate of Mother-to-Child Transmission of HIV-1

... cient HIV-1 vaccine immunogens, the MTCT model offers the opportunity to explore whether some specific neutralizing anti- bodies are associated with ...to HIV in the presence of preexisting ... See full document

7

Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones

Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones

... on HIV-1-infected cells, which can lead to detection of responses that does not reflect recognition of infected cells (7, ...of HIV-1-infected cells (8). Given the limited sampling of ... See full document

11

Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins

Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins

... neutralize HIV-1 in vitro and to protect in vivo against HIV-1 in animal ...of specific NABs to protect against SHIV infec- tion, and found that efficient immunity is ... See full document

9

HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities

HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities

... ALVAC/AIDSVax HIV-1 vaccine clinical trial showed an estimated vaccine efficacy of ...the HIV-1 envelope (Env) variable region 2 (V2) focused on residue 169, which is included in the epitope ... See full document

12

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques

A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques

... provide multi- ple advantages over SOSIP or NFL gp140 trimeric ...response against the V2 hot-spot region or generate ADCC activity against HIV-infected ... See full document

15

Vaccine-Induced HIV-1 Envelope gp120 Constant Region 1-Specific Antibodies Expose a CD4-Inducible Epitope and Block the Interaction of HIV-1 gp140 with Galactosylceramide

Vaccine-Induced HIV-1 Envelope gp120 Constant Region 1-Specific Antibodies Expose a CD4-Inducible Epitope and Block the Interaction of HIV-1 gp140 with Galactosylceramide

... of antibodies against a structurally heteroge- neous site of immune pressure within HIV-1 envelope protein variable regions 1 and ... See full document

12

Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma

Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma

... of HIV-2 KR.X7 /HIV-1 V3 chimeras by polyclonal HIV-1-positive ...plasma antibodies for ...effectively against 447-52D and F425 B4e8 neutralization than did the V3 YU2 ... See full document

20

Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies

Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies

... Although antibodies to the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein have been studied extensively for their ability to block viral infectivity, little data are ... See full document

13

Glycan dependent HIV specific neutralizing antibodies bind to cells of uninfected individuals

Glycan dependent HIV specific neutralizing antibodies bind to cells of uninfected individuals

... neutralizing antibodies (bNAbs) against the human immunodeficiency virus (HIV) have recently been shown to prevent transmission of the virus, suppress viral replication, and delay plasma viral ... See full document

7

Natural variation in Fc glycosylation of HIV specific antibodies impacts antiviral activity

Natural variation in Fc glycosylation of HIV specific antibodies impacts antiviral activity

... response against HIV remains a daunting goal, data from both natural infection and vaccine-induced immune responses suggest that it may be possible to induce antibodies with enhanced Fc effector ... See full document

11

Antibodies against Mycobacterial Proteins as Biomarkers for HIV-Associated Smear-Negative Tuberculosis

Antibodies against Mycobacterial Proteins as Biomarkers for HIV-Associated Smear-Negative Tuberculosis

... in HIV ⫹ individuals (reviewed in reference ...tuberculosis-infected HIV ⫹ individuals, the risk of development of TB can be over 10% per year (28–30), while in HIV ⫺ individuals, it is only around ... See full document

8

Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies

Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies

... neutralizing antibodies have recently been reported ...structure-specific antibodies may be generated with reasonable frequency during natural HIV-1 infection and that such ... See full document

8

CHARACTERIZATION OF RABBIT MONOCLONAL ANTIBODIES PRODUCED BY AN HIV-1 VACCINE

CHARACTERIZATION OF RABBIT MONOCLONAL ANTIBODIES PRODUCED BY AN HIV-1 VACCINE

... Previously, most of the immunogenicity studies in this field used polyclonal sera, which makes it difficult to link the observed antibody activities with a particular antibody component in a polyclonal serum. Here, the ... See full document

37

Show all 10000 documents...